An Unusual Case of Granulomatous Lung Disease: A Clinical Pathology Conference Held by the Department of Rheumatology at Hospital for Special Surgery

Thatayatikom A Thatayatikom S White AJ Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature Ann Allergy Asthma Immun 200595 293–30010.1016/S1081-1206(10)61228-8

Lukela M DeGuzman D Weinberger S Clinical problem-solving. Unfashionably late N Engl J Med 2005352 64–6910.1056/NEJMcps041234

Shmerling RH Delbanco TL The rheumatoid factor: an analysis of clinical utility Am J Med 199191 528–53410.1016/0002-9343(91)90190-9

du Bois RM Wells AU Hochberg MC Silman AJ Smolen JS The lung in rheumatic diseases Rheumatology 20033 Sage CA: Los Angeles, CA Mosby 315–323

Keystone EC The utility of tumour necrosis factor blockade in orphan diseases Ann Rheum Dis 200463 Suppl 2 ii79–ii8310.1136/ard.2004.028498

Baughman RP Pulmonary sarcoidosis Clin Chest Med 200425 521–53010.1016/j.ccm.2004.04.006

Baughman RP Lower EE Infliximab for refractory sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 200118 70–74

Doty JD Mazur JE Judson MA Treatment of sarcoidosis with infliximab Chest 2005127 1064–107110.1378/chest.127.3.1064

Gill KR Mahadevan U Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease Inflamm Bowel Dis 200511 210–21210.1097/00054725-200502000-00020

Roberts SD Wilkes DS Burgett RA Refractory sarcoidosis responding to infliximab Chest 2003124 2028–203110.1378/chest.124.5.2028

Ulbricht KU Stoll M Bierwirth J Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis Arthritis Rheum 200348 3542–354310.1002/art.11357

Yee AM Pochapin MB Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy Ann Intern Med 2001135 27–31

Moller DR Treatment of sarcoidosis—from a basic science point of view J Intern Med 2003253 31–4010.1046/j.1365-2796.2003.01075.x

Sandborn WJ Hanauer SB Katz S Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial Gastroenterology 2001121 1088–109410.1053/gast.2001.28674

Utz JP Limper AH Kalra S Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis Chest 2003124 177–18510.1378/chest.124.1.177

The WGET Research Group Etanercept plus standard therapy for Wegener's granulomatosis N Engl J Med 2005352 351–36110.1056/NEJMoa041884

Khanna D McMahon M Furst DE Safety of tumour necrosis factor-alpha antagonists Drug Safety 200427 307–32410.2165/00002018-200427050-00003

Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L, et al. (2005) Treatment of therapy-resistant sarcoidosis with adalimumab. Clin Rheumatol 1–2